Literature DB >> 15479672

Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse.

J H Allen1, G M de Moore, R Heddle, J C Twartz.   

Abstract

BACKGROUND AND AIMS: To explore the association between chronic cannabis abuse and a cyclical vomiting illness that presented in a series of cases in South Australia.
METHODS: Nineteen patients were identified with chronic cannabis abuse and a cyclical vomiting illness. For legal and ethical reasons, all patients were counselled to cease all cannabis abuse. Follow up was provided with serial urine drug screen analysis and regular clinical consultation to chart the clinical course. Of the 19 patients, five refused consent and were lost to follow up and five were excluded on the basis of confounders. The remaining nine cases are presented here and compared with a published case of psychogenic vomiting.
RESULTS: In all cases, including the published case, chronic cannabis abuse predated the onset of the cyclical vomiting illness. Cessation of cannabis abuse led to cessation of the cyclical vomiting illness in seven cases. Three cases, including the published case, did not abstain and continued to have recurrent episodes of vomiting. Three cases rechallenged themselves after a period of abstinence and suffered a return to illness. Two of these cases abstained again, and became and remain well. The third case did not and remains ill. A novel finding was that nine of the 10 patients, including the previously published case, displayed an abnormal washing behaviour during episodes of active illness.
CONCLUSIONS: We conclude that chronic cannabis abuse was the cause of the cyclical vomiting illness in all cases, including the previously described case of psychogenic vomiting.

Entities:  

Mesh:

Year:  2004        PMID: 15479672      PMCID: PMC1774264          DOI: 10.1136/gut.2003.036350

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  Is cyclic vomiting syndrome related to migraine?

Authors:  B U Li; R D Murray; L A Heitlinger; J L Robbins; J R Hayes
Journal:  J Pediatr       Date:  1999-05       Impact factor: 4.406

2.  Cyclic vomiting as a form of epilepsy in children.

Authors:  J G MILLICHAP; C T LOMBROSO; W G LENNOX
Journal:  Pediatrics       Date:  1955-06       Impact factor: 7.124

3.  Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders.

Authors:  T J Crowley; M J Macdonald; E A Whitmore; S K Mikulich
Journal:  Drug Alcohol Depend       Date:  1998-03-01       Impact factor: 4.492

4.  Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study.

Authors:  R W McCallum; I Soykan; K R Sridhar; D A Ricci; R C Lange; M W Plankey
Journal:  Aliment Pharmacol Ther       Date:  1999-01       Impact factor: 8.171

Review 5.  Cannabis and endogenous cannabinoid systems.

Authors:  S R Childers; C S Breivogel
Journal:  Drug Alcohol Depend       Date:  1998 Jun-Jul       Impact factor: 4.492

Review 6.  Pharmacology of cannabinoid CB1 and CB2 receptors.

Authors:  R G Pertwee
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

7.  Psychogenic vomiting.

Authors:  O W Hill
Journal:  Gut       Date:  1968-06       Impact factor: 23.059

8.  Recreational drug use and the risk of primary infertility.

Authors:  B A Mueller; J R Daling; N S Weiss; D E Moore
Journal:  Epidemiology       Date:  1990-05       Impact factor: 4.822

Review 9.  Cannabis and the brain.

Authors:  Leslie Iversen
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

10.  Cannabinoid receptor localization in brain.

Authors:  M Herkenham; A B Lynn; M D Little; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

View more
  101 in total

1.  Management of Pediatric Cannabinoid Hyperemesis Syndrome: A Review.

Authors:  Justin P Reinert; O'Neill Niyamugabo; Kiersi S Harmon; Norman E Fenn
Journal:  J Pediatr Pharmacol Ther       Date:  2021-05-19

2.  Cyclic vomiting syndrome and functional vomiting in adults: association with cannabinoid use in males.

Authors:  R S Choung; G R Locke; R M Lee; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2011-09-27       Impact factor: 3.598

3.  Cannabinoid hyperemesis: a case series of 98 patients.

Authors:  Douglas A Simonetto; Amy S Oxentenko; Margot L Herman; Jason H Szostek
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

4.  Cannabinoid hyperemesis.

Authors:  Kim Wild; Hugh Wilson
Journal:  BMJ Case Rep       Date:  2010-09-07

5.  Cannabinoid hyperemesis syndrome.

Authors:  Jose M Roca-Pallín; Hugo López-Pelayo; Gisela Sugranyes; Maria M Balcells-Oliveró
Journal:  CNS Neurosci Ther       Date:  2013-12       Impact factor: 5.243

6.  Cyclic vomiting presentations following marijuana liberalization in Colorado.

Authors:  Howard S Kim; John D Anderson; Omeed Saghafi; Kennon J Heard; Andrew A Monte
Journal:  Acad Emerg Med       Date:  2015-04-22       Impact factor: 3.451

7.  Coronary vasospasm complicating cannabinoid hyperemesis syndrome.

Authors:  Sophie Pierard; Philippe Hantson
Journal:  J Cardiol Cases       Date:  2017-01-20

Review 8.  Diet and Complementary Medicine for Chronic Unexplained Nausea and Vomiting and Gastroparesis.

Authors:  Ekta Gupta; Linda A Lee
Journal:  Curr Treat Options Gastroenterol       Date:  2016-12

9.  Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse.

Authors:  Siva P Sontineni; Sanjay Chaudhary; Vijaya Sontineni; Stephen J Lanspa
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

Review 10.  The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information.

Authors:  Arun Swaminath; Eric P Berlin; Adam Cheifetz; Ed Hoffenberg; Jami Kinnucan; Laura Wingate; Sarah Buchanan; Nada Zmeter; David T Rubin
Journal:  Inflamm Bowel Dis       Date:  2019-02-21       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.